Literature DB >> 7716785

The dental amalgam mercury controversy--inorganic mercury and the CNS; genetic linkage of mercury and antibiotic resistances in intestinal bacteria.

F L Lorscheider1, M J Vimy, A O Summers, H Zwiers.   

Abstract

Mercury (Hg) vapor exposure from dental amalgam has been demonstrated to exceed the sum of all other exposure sources. Therefore the effects of inorganic Hg exposure upon cell function in the brain and in the intestinal bacteria have recently been examined. In rats we demonstrate that ADP-ribosylation of tubulin and actin brain proteins is markedly inhibited, and that ionic Hg can thus alter a neurochemical reaction involved with maintaining neuron membrane structure. In monkeys we show that Hg, specifically from amalgam, will enrich the intestinal flora with Hg-resistant bacterial species which in turn also become resistant to antibiotics.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7716785     DOI: 10.1016/0300-483x(94)02964-v

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  4 in total

1.  2,3-Dimercaptopropanol inhibits Ca2+ transport in microsomes from brain but not from fast-skeletal muscle.

Authors:  E B Quinhones; D O Souza; J B Rocha
Journal:  Neurochem Res       Date:  2001-03       Impact factor: 3.996

Review 2.  Clinical Effects of Mercury in Conservative Dentistry: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials.

Authors:  Romeo Patini; Gianrico Spagnuolo; Federica Guglielmi; Edoardo Staderini; Michele Simeone; Andrea Camodeca; Patrizia Gallenzi
Journal:  Int J Dent       Date:  2020-08-12

3.  Is dental amalgam safe for humans? The opinion of the scientific committee of the European Commission.

Authors:  Joachim Mutter
Journal:  J Occup Med Toxicol       Date:  2011-01-13       Impact factor: 2.646

4.  Natural health products, modulation of immune function and prevention of chronic diseases.

Authors:  Pierre S Haddad; Georges A Azar; Simon Groom; Michel Boivin
Journal:  Evid Based Complement Alternat Med       Date:  2005-10-20       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.